113 related articles for article (PubMed ID: 25339038)
1. Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.
Bian J; Li B; Kou XJ; Wang XN; Sun XX; Ming L
Asian Pac J Cancer Prev; 2014; 15(19):8409-11. PubMed ID: 25339038
[TBL] [Abstract][Full Text] [Related]
2. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
Liu F; Du F; Chen X
World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
[TBL] [Abstract][Full Text] [Related]
3. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
Zhang LL; Shao SL; Wu Y
Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
[TBL] [Abstract][Full Text] [Related]
5. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
[TBL] [Abstract][Full Text] [Related]
6. LyGDI is a promising biomarker for ovarian cancer.
Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X
Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
[TBL] [Abstract][Full Text] [Related]
7. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of multi-tumor markers protein biochip in the diagnosis of pulmonary carcinoma].
Liang Z; Wang HF; Wu AZ; Cai JH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov; 30(11):2516-8. PubMed ID: 21097421
[TBL] [Abstract][Full Text] [Related]
9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.
Nielsen JS; Jakobsen E; Hølund B; Bertelsen K; Jakobsen A
Int J Gynecol Cancer; 2004; 14(6):1086-96. PubMed ID: 15571614
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma.
Missaoui N; Salhi S; Bdioui A; Mestiri S; Abdessayed N; Mokni M; Yacoubi MT
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2545-2551. PubMed ID: 30256049
[TBL] [Abstract][Full Text] [Related]
12. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.
Lea J; Sharma R; Yang F; Zhu H; Ward ES; Schroit AJ
Oncotarget; 2017 Feb; 8(9):14395-14407. PubMed ID: 28122335
[TBL] [Abstract][Full Text] [Related]
13. The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study.
Fotopoulou C; Sehouli J; Ewald-Riegler N; de Gregorio N; Reuss A; Richter R; Mahner S; Kommoss F; Schmalfeldt B; Fehm T; Hanker L; Wimberger P; Canzler U; Pfisterer J; Kommoss S; Hauptmann S; du Bois A;
Int J Gynecol Cancer; 2015 Sep; 25(7):1248-52. PubMed ID: 25978292
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
Fan HY; Duan DM; Liu YF
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
[TBL] [Abstract][Full Text] [Related]
15. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer.
Yang D; Li H; Sun X; Yang S; Wang K; Liu Z
Sci Rep; 2020 Nov; 10(1):20056. PubMed ID: 33208875
[TBL] [Abstract][Full Text] [Related]
17. Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies.
Da Gama Duarte J; Quigley LT; Young AR; Hayashi M; Miyazawa M; Lopata A; Mancuso N; Mikami M; Behren A; Meeusen E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681879
[TBL] [Abstract][Full Text] [Related]
18. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer.
Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N
Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
